Affinity Asset Advisors, LLC Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$286.8T
Holdings
65
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (65 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MDGLMADRIGAL PHARMACEUTICALS INC | 145,600 | $33.6T | 11.73% | Call |
| 2 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 550,000 | $17.5T | 6.10% | |
| 3 | ESTAESTABLISHMENT LABS HLDGS INC | 211,608 | $14.5T | 5.06% | |
| 4 | 290ACHINOOK THERAPEUTICS INC | 321,017 | $12.3T | 4.30% | |
| 5 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,600,000 | $12.0T | 4.20% | |
| 6 | MORFMORPHIC HLDG INC | 201,887 | $11.6T | 4.04% | |
| 7 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,050,118 | $11.5T | 4.01% | |
| 8 | BIIBBIOGEN INC | 40,000 | $11.4T | 3.97% | |
| 9 | VKTXVIKING THERAPEUTICS INC | 650,000 | $10.5T | 3.67% | Put |
| 10 | KURAKURA ONCOLOGY INC | 910,317 | $9.6T | 3.36% | |
| 11 | VRNAVERONA PHARMA PLC | 447,667 | $9.5T | 3.30% | |
| 12 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 12,000,000 | $9.5T | 3.30% | |
| 13 | ACLXARCELLX INC | 226,275 | $7.2T | 2.49% | |
| 14 | BBIOBRIDGEBIO PHARMA INC | 411,133 | $7.1T | 2.47% | Put |
| 15 | PRTAPROTHENA CORP PLC | 100,000 | $6.8T | 2.38% | |
| 16 | FGENEURFIBROGEN INC | 2,306,600 | $6.2T | 2.17% | Put |
| 17 | CNTACENTESSA PHARMACEUTICALS PLC | 900,723 | $5.6T | 1.94% | |
| 18 | CATBUSDASTRIA THERAPEUTICS INC | 650,875 | $5.4T | 1.89% | |
| 19 | ASNDASCENDIS PHARMA A S | 57,760 | $5.2T | 1.80% | |
| 20 | IMVTIMMUNOVANT INC | 260,000 | $4.9T | 1.72% | |
| 21 | AZNASTRAZENECA PLC | 60,000 | $4.3T | 1.50% | |
| 22 | INZYINOZYME PHARMA INC | 751,796 | $4.2T | 1.46% | |
| 23 | CYTKCYTOKINETICS INC | 125,148 | $4.1T | 1.42% | |
| 24 | AUTLAUTOLUS THERAPEUTICS PLC | 1,589,017 | $3.8T | 1.32% | |
| 25 | IMTXIMMATICS N.V | 300,000 | $3.5T | 1.21% | |
| 26 | ESPR 4 11/15/25ESPERION THERAPEUTICS INC NE | 6,925,000 | $3.4T | 1.20% | |
| 27 | SWTXSPRINGWORKS THERAPEUTICS INC | 130,000 | $3.4T | 1.19% | |
| 28 | VTYXVENTYX BIOSCIENCES INC | 100,696 | $3.3T | 1.15% | |
| 29 | VRDNVIRIDIAN THERAPEUTICS INC | 130,400 | $3.1T | 1.08% | Call |
| 30 | RETAEURREATA PHARMACEUTICALS INC | 29,105 | $3.0T | 1.03% | |
| 31 | TCE2CELLDEX THERAPEUTICS INC NEW | 87,031 | $3.0T | 1.03% | |
| 32 | XENEXENON PHARMACEUTICALS INC | 60,376 | $2.3T | 0.81% | |
| 33 | —THESEUS PHARMACEUTICALS INC | 240,244 | $2.2T | 0.78% | |
| 34 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 4,900,000 | $2.2T | 0.77% | |
| 35 | —VINCERX PHARMA INC | 1,492,771 | $1.9T | 0.68% | |
| 36 | LIANYLIANBIO | 800,676 | $1.8T | 0.64% | |
| 37 | CABACABALETTA BIO INC | 125,000 | $1.6T | 0.56% | |
| 38 | KALVKALVISTA PHARMACEUTICALS INC | 178,292 | $1.6T | 0.56% | |
| 39 | —PRECIGEN INC | 1,500,000 | $1.5T | 0.53% | |
| 40 | ADCTADC THERAPEUTICS SA | 600,000 | $1.3T | 0.45% | |
| 41 | WHWKAADI BIOSCIENCE INC | 187,675 | $1.3T | 0.45% | |
| 42 | ALDXALDEYRA THERAPEUTICS INC | 150,000 | $1.3T | 0.44% | |
| 43 | NVLSEURALPINE IMMUNE SCIENCES INC | 118,891 | $1.2T | 0.43% | |
| 44 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.2T | 0.41% | |
| 45 | VSAREURARAVIVE INC | 894,800 | $1.1T | 0.39% | Put |
| 46 | IFRXINFLARX NV | 240,200 | $1.1T | 0.37% | |
| 47 | MLYSMINERALYS THERAPEUTICS INC | 62,500 | $1.1T | 0.37% | |
| 48 | NRIXNURIX THERAPEUTICS INC | 100,000 | $999.0B | 0.35% | |
| 49 | BCABBIOATLA INC | 325,000 | $975.0B | 0.34% | |
| 50 | APLSAPELLIS PHARMACEUTICALS INC | 10,000 | $911.0B | 0.32% | |
| 51 | AXSMAXSOME THERAPEUTICS INC | 12,500 | $898.3B | 0.31% | |
| 52 | MISTMILESTONE PHARMACEUTICALS IN | 300,068 | $855.2B | 0.30% | |
| 53 | MIRMMIRUM PHARMACEUTICALS INC | 30,000 | $776.1B | 0.27% | |
| 54 | PBYIPUMA BIOTECHNOLOGY INC | 202,349 | $714.3B | 0.25% | |
| 55 | PCVXVAXCYTE INC | 13,923 | $695.3B | 0.24% | |
| 56 | JSPRJASPER THERAPEUTICS INC | 476,948 | $653.4B | 0.23% | |
| 57 | IMTXIMMATICS N.V | 187,204 | $632.8B | 0.22% | |
| 58 | —TALARIS THERAPEUTICS INC | 200,000 | $608.0B | 0.21% | |
| 59 | VIRVIR BIOTECHNOLOGY INC | 20,000 | $490.6B | 0.17% | |
| 60 | SPYSPDR S&P 500 ETF TR | 18,087 | $488.3B | 0.17% | |
| 61 | NUVBNUVATION BIO INC | 250,000 | $450.0B | 0.16% | |
| 62 | —NLS PHARMACEUTICS LTD | 400,000 | $440.0B | 0.15% | |
| 63 | CNTXCONTEXT THERAPEUTICS INC | 267,574 | $428.1B | 0.15% | |
| 64 | NAMSNEWAMSTERDAM PHARMA COMPANY | 37,000 | $77.3B | 0.03% | |
| 65 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $13.9B | 0.00% |